| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |

( McArdle Memorial Laboratory, The Medical School, University of Wisconsin, Madison, Wis.)
The activities of glucose-6-phosphatase, glutamate dehydrogenase, and choline oxidase were determined in some or all of ten rat hepatomas, including the Novikoff, Dunning L-C18, McCoy MDAB, and the Morris 3683, 3924A, and 5123 hepatomas, together with primary hepatomas produced by feeding ethionine or 3'-methyl-4-dimethylaminoazobenzene, and transplanted hepatomas derived from the primary tumors induced with ethionine.
Of these neoplasms, only the Morris hepatoma 5123, the primary and transplanted ethionine-induced hepatomas, and one of the 3'-methyl-4-dimethylaminoazobenzeneinduced tumors possessed significant glucose-6-phosphatase activity. These same tumors in addition to the Dunning L-C18 hepatoma had demonstrable glutamate dehydrogenase activity, whereas the other neoplasms tested failed to show significant activity of this enzyme. With the exception of the primary dye-induced neoplasm, which was not tested, only those neoplasms having significant glucose-6-phosphatase activities showed any choline oxidase activity.
Of those neoplasms tested for tryptophan peroxidase activity only the Morris hepatoma 5123, the primary ethionine-induced hepatoma, and some of the Dunning L-C18 hepatomas had any demonstrable activity of this enzyme. In contrast to most of the enzymatic activities reported here, the threonine dehydrase activity of the Morris hepatoma 5123 was of the order of 40 times the level of this enzyme in the livers of animals bearing this tumor.
The significance of these results in relation to the biochemical and morphologic classification of experimental hepatic carcinomas, as well as the importance of studying the biochemistry of slowly growing, highly differentiated experimental neoplasms such as the Morris hepatoma 5123, is discussed.
* This work was supported in part by a grant (No. C-646) to Prof. Van R. Potter from the National Cancer Institute, National Institutes of Health, U.S. Public Health Service.
Lillian Israel Memorial Fellow in Cancer Research of the American Cancer Society, 19571960.
Received 4/ 4/60.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |